Estrone sulfate sodium

TargetMol
Product Code: TAR-T36857
Supplier: TargetMol
CodeSizePrice
TAR-T36857-1mg1mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-5mg5mg£270.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-10mg10mg£370.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-1mL1 mL * 10 mM (in DMSO)£402.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-25mg25mg£704.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-50mg50mg£1,066.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-100mg100mg£1,581.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T36857-200mg200mg£2,368.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Estrone 3-sulfate is an endogenous steroid and an estrogen ester that is biologically inactive. It is converted by steroid sulfatase into estrone . Estrone 3-sulfate has been investigated as a ligand for targeting organic anion transporting polypeptides f
CAS:
438-67-5
Formula:
C18H21NaO5S
Molecular Weight:
372.41
Pathway:
Metabolism
Purity:
0.98
SMILES:
O=C1CC[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OS(=O)([O-])=O)=C4)[C@@]3([H])CC[C@]12C.[Na+]
Target:
Endogenous Metabolite

References

Emre Karakus, et al. Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6). Front Pharmacol. 2018;9:941. Published 2018 Aug 21. Nilasha Banerjee, et al. Estrone-3-sulphate, a potential novel ligand for targeting breast cancers. PLoS One. 2013 May 22;8(5):e64069.